Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$5,166,042
-$647,777 QoQ
Shares Held
40,890
-2.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#574
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 27%
Shared 0%
None 73%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meridian Wealth Management, LLC holds $80,207,351 across 13 Drug Manufacturers - General names. GILD ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
77,358 | $19,466,367 | |
| 2 | LLY |
ELI LILLY & Co
|
15,030 | $18,027,434 | |
| 3 | JNJ |
Johnson & Johnson
|
53,587 | $13,609,490 | |
| 4 | MRK |
Merck & Co., Inc.
|
79,604 | $10,229,114 | |
| 5 | AMGN |
Amgen Inc
|
14,339 | $5,192,438 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
40,890 | $5,166,042 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
52,891 | $3,047,579 | |
| 8 | PFE |
Pfizer Inc
|
103,774 | $2,498,877 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,166,042 | 40,890 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $5,813,819 | 41,715 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,138,264 | 41,863 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $4,647,459 | 41,869 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,741,466 | 42,766 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,664,193 | 41,626 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,015,785 | 43,475 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,558,924 | 42,449 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $3,085,363 | 42,121 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,305,775 | 40,807 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,727,067 | 23,046 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $905,803 | 11,753 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $955,067 | 11,511 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $925,033 | 10,775 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,470,936 | 23,844 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,637,865 | 42,677 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,562,651 | 43,106 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,843,480 | 39,161 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $2,446,356 | 35,023 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $2,154,973 | 31,295 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $1,613,940 | 24,972 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,214,895 | 20,853 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,402,059 | 22,188 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $1,608,122 | 20,901 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $805,987 | 10,781 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||